However, human hypertrophic cardiomyopathy tissues exhibited significantly reduced acylcarnitines, whereas the analysis of blood acylcarnitines in our desmin knock-out mice showed an opposite picture. This evidence concerns the gene DES and hypertrophic cardiomyopathy.